In the M1 stage, the sensitivity of AFP, CEA, CA125, CA199, and CA242 to detect gastric cancer was 34.33%, 49.25%, 62.69%, 52.24%, 52.24%, respectively, and the sensitivity of combined detection was 71.64%. This evidence concerns the gene CEACAM5 and gastric cancer.